Summary Caffeine is a methylxanthine derived from plant foods such as coffee beans and tea leaves, and has multiple biological activities against physiological response and several diseases. Although there are some reports about the direct effect of caffeine against anti-lipid accumulation in vitro, the effect of caffeine on lipid accumulation in adipocytes through stimulating intestinal epithelial cells is unknown. Since direct treatment with caffeine to 3T3-L1 cells did not affect lipid accumulation, we determined whether caffeinestimulated intestinal epithelial Caco-2 cells influence the lipid accumulation in 3T3-L1 adipocytes. Caco-2 cells were cultured on a transwell insert with or without caffeine for 24 h. Subsequently, the basolateral component of the Caco-2 cell culture on the transwell was collected and termed caffeine-conditioning medium (CCM). When 3T3-L1 adipocytes were incubated with CCM, CCM decreased lipid accumulation and suppressed gene expression of proliferator activated receptor (PPAR) ␥ and CCAAT/enhancer binding protein (C/EBP) ␣ in 3T3-L1 adipocytes. Furthermore, CCM decreased the expression of C/EBP␤ and C/EBP␦ at the protein level, but not at the mRNA level. We observed that a proteasome inhibitor, MG132, inhibited CCM-caused down-expression of C/EBP␤ and C/EBP␦ proteins, and that CCM promoted the ubiquitination level of C/EBP␤ and C/EBP␦ proteins. Protein microarray analysis showed caffeine suppresses the secretion of inflammatory cytokines, interleukin-8 and plasminogen activator inhibitor-1 from Caco-2 cells. These results suggest that caffeine indirectly suppresses lipid accumulation in 3T3-L1 adipocytes through decreasing secretion of inflammatory cytokines from Caco-2 cells. Key Words caffeine, adipogenesis, 3T3-L1 adipocytes, Caco-2 cells Obesity is a risk factor for multiple lifestyle diseases such as apoplexy, heart disease and diabetes (1, 2). Adipocytes play a critical role in regulating lipid metabolism and energy balance, which are associated with adiposity (3). An increase in the number of differentiated mature adipocytes and excess accumulation of body fat leads to adiposity. Adipocytes accumulate intracellular lipids during differentiation. As an in vitro model system for adipogenesis, murine 3T3-L1 cells, which were originally derived from mouse embryos, are often used. Differentiation of 3T3-L1 cells is induced by exposure to the inducers, such as 3-isobutyl-1-methylxanthine (IBMX), dexamethasone and insulin, and is responsible for the accumulation of a large amount of intracellular lipid droplets during adipocyte differentiation. Adipogenesis, the differentiation process for producing adipocytes, is a complex process that is regulated by various transcription factors and their related genes. The expression levels of CCAAT/enhancer binding protein (C/EBP) ␤ and C/EBP␦, as transcriptional factors, are increased in the early phase of adipocyte differentiation (4). Subsequently, these transcription factors up-regulate proliferator activated receptor (PPAR) ␥ and C/EBP␣, as the master regulators of adipocyte differentiation (5). PPAR␥ and C/EBP␣ have been shown to regulate the expression of lipid and glucose metabolism genes, such as fatty acid binding protein 4, CD36, adiponectin and glucose transporter 4 (GLUT4) (6, 7).
Obesity is a risk factor for multiple lifestyle diseases such as apoplexy, heart disease and diabetes (1, 2) . Adipocytes play a critical role in regulating lipid metabolism and energy balance, which are associated with adiposity (3) . An increase in the number of differentiated mature adipocytes and excess accumulation of body fat leads to adiposity. Adipocytes accumulate intracellular lipids during differentiation. As an in vitro model system for adipogenesis, murine 3T3-L1 cells, which were originally derived from mouse embryos, are often used. Differentiation of 3T3-L1 cells is induced by exposure to the inducers, such as 3-isobutyl-1-methylxanthine (IBMX), dexamethasone and insulin, and is responsible for the accumulation of a large amount of intracellular lipid droplets during adipocyte differentiation. Adipogenesis, the differentiation process for producing adipocytes, is a complex process that is regulated by various transcription factors and their related genes. The expression levels of CCAAT/enhancer binding protein (C/EBP) ␤ and C/EBP␦, as transcriptional factors, are increased in the early phase of adipocyte differentiation (4) . Subsequently, these transcription factors up-regulate proliferator activated receptor (PPAR) ␥ and C/EBP␣, as the master regulators of adipocyte differentiation (5) . PPAR␥ and C/EBP␣ have been shown to regulate the expression of lipid and glucose metabolism genes, such as fatty acid binding protein 4, CD36, adiponectin and glucose transporter 4 (GLUT4) (6, 7) .
As the in vitro model system for absorption and metabolism of intestinal epithelial cells, many researchers have used human epithelial Caco-2 cells, which are derived from human colon adenocarcinoma but this cell linage exhibits small intestinal epithelial cell-like characteristics (8, 9) . Moreover, Caco-2 cells secrete cytokines such as tumor necrosis factor-␣ (TNF-␣), interleukin (IL)-8 and monocyte chemotactic protein 1 (10) . Cytokines are classified as pro-inflammatory cytokines, such as IL-1, IL-8 and TNF-␣, and anti-inflammatory cytokines, such as IL-4 and IL-10. IL-4 and granulocytecolony stimulating factor (G-CSF) which are known to suppress adipocyte differentiation (11, 12) . Thus, intestinal epithelial cell-derived cytokines might regulate adipogenesis and adipocyte differentiation.
The regulation of adipocyte differentiation by food factors is a crucial therapeutic strategy for prevention and improvement of obesity and its related metabolic syndrome. However, little is known about the effect of food factors on adipocyte differentiation through the stimulation of intestinal epithelial cells. Caffeine (1,3,7-trimethylxanthine) is one of the methylxanthines and is included in coffee beans and tea leaves. Several studies have reported that caffeine increases lipolysis and energy expenditure (13, 14) and inhibits hypertrophy of mature adipocytes via suppression of glucose intake (15) . Furthermore, it is reported that the intake of a diet containing caffeine reduced the weight of parametrical white adipose tissues in rats (16) , and the weight of intraperitoneal adipose tissues in mice (17) . To examined the effect of epithelial cells stimulated by caffeine on lipid accumulation in adipocytes, caffeine was added to the apical side of Caco-2 monolayers in a transwell, and 3T3-L1 cells were treated with the permeated basolateral medium, termed caffeine-conditioning medium (CCM).
MATERIALS AND METHODS
Cell culture and treatment. Caco-2 cells were cultured in Dulbecco's modified Eagle medium (DMEM) containing high glucose (4.5 g/L glucose) supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 g/mL streptomycin. 3T3-L1 cells were cultured in Dulbecco modified Eagle's medium supplemented with 10% calf serum, 100 U/mL penicillin and 100 g/mL streptomycin. These cells were cultured in a CO2 incubator with 5% CO2/95% air at 37˚C. Adipocytes differentiation of 3T3-L1 cells was performed as described previously (18) . Briefly, 3T3-L1 cells to mature adipocytes were induced by treatment with 0.5 mmol/L IBMX, 1 mol/L dexamethasone and 10 g/mL insulin in DMEM containing high glucose for 3 d after the cells reached confluence. Then, the cells were treated with 10 g/mL insulin in DMEM containing high glucose for an additional 3 d. Thereafter, they were maintained in DMEM containing high glucose alone for an additional 2 d and used as mature 3T3-L1 cells.
An intestinal permeability system using Caco-2 cells and 3T3-L1 cells was constructed with minor modification of the method described previously (19) . Briefly, Caco-2 cells were seeded on transwell inserts (polyethylene terephthalate track-etched membrane, 23.1-mm diameter and 0.4 m pore size, BD Biosciences, Durham, NC) in a 6-well plate at a density of 8ϫ10 5 cells/ insert (4.2 cm 2 /insert). Culture medium was replaced three times a week for 20-22 d. When the transepithelial electrical resistance value of the monolayers, which was measured with a Millicell-ERS instrument (Millipore Co., Bedford, MA) was 1,985Ϯ109 Ω·cm 2 , the Caco-2 cells were used in experiments. Caffeine at 10 mmol/L was applied to the apical compartment of Caco-2 cells on transwell inserts for 24 h. Then, CCM was collected from the basolateral compartment, and 3T3-L1 cells were incubated in CCM. The culture system used is illustrated in Fig. 1 .
Sudan II staining. Post-confluent 3T3-L1 cells were cultured in CCM with 0.5 mmol/L IBMX, 1 mol/L dexamethasone and 10 g/mL insulin for 3 d. Then, culture medium was replaced with fresh medium and the cells were cultured for an additional 5 d. Determination of lipid accumulation in 3T3-L1 cells was performed by Sudan II staining as described previously (18) . Lipid accumulation was also determined by direct application of caffeine to the cells.
Quantitative real-time PCR (qPCR). Total RNA was extracted from 3T3-L1 cells and Caco-2 cells using TRlzol Reagent (Invitrogen, Carlsbad, CA), and cDNAs were synthesized by reverse transcription using ReverTra Ace qPCR RT Kit (Toyobo, Osaka, Japan). qPCR was per- formed on a real-time PCR system (TaKaRa PCR Thermal Cycler Dice, Takara Bio, Otsu, Japan) using SYBR Premix Ex Taq II (Takara Bio). The primer sequences are described in Table 1 . The relative gene expression levels were calculated by the comparative Ct method, using the expression of the Actb or ACTB gene as an internal control.
Western blotting. Western blot analysis was performed as described previously (20) . In brief, 3T3-L1 cells were lysed in RIPA buffer, and the cell lysates were subjected to SDS-PAGE and analyzed by western blotting using the following primary antibodies: rabbit polyclonal antibodies [anti-PPAR␥, H-100; anti-C/EBP␤, C-19; and anti-C/EBP␦, C-22 (Santa Cruz Biotechnology, Santa Cruz, CA)], and goat polyclonal anti-C/EBP␣, N-19 (Santa Cruz Biotechnology) antibody, and mouse monoclonal anti-␤-actin (clone, C4; Santa Cruz Biotechnology) antibody. The immunoreactive proteins were incubated with horseradish peroxidase-conjugated secondary antibodies and reacted with Immunostar LD (Wako Pure Chemical Industries, Ltd., Osaka, Japan).
Measurement of caffeine concentration. Caffeine at 10 mmol/L was applied to Caco-2 monolayers on the transwell inserts in a 6-well plate for 24 h. The medium of the basolateral side was collected. To extract caffeine, chloroform/2-propanol (85 : 15, v/v) was mixed with the collected medium vigorously for 30 s. After centrifugation at 1,000 ϫg for 10 min, the aqueous layer was collected, evaporated with a centrifugal concentrator and dissolved in 50% methanol. Caffeine permeating through Caco-2 cells to the medium of the basolateral side was analyzed by a HPLC system consisting of Shimadzu liquid chromatograph model CBM-20A (Kyoto, Japan) equipped with an autosampler using a Cadenza CL-C18 column (250ϫ4.6 mm inner diameter, 3 m particle diameter; Imtakt, Kyoto, Japan) on a flow rate at 0.5 mL/min, column temperature at 40˚C and UV detection at 275 nm. The mobile phase consisted of isocratic solvent (0.05% acetic acid/acetonitrile, 88 : 12, v/v).
Secretory cytokine analysis. Caffeine at 10 mmol/L was added on the apical side of Caco-2 cells for 24 h. Then, the medium from the basolateral side was subjected to a Proteome Profiler Human Cytokine Array Panel A Array Kit (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Statistical analysis. All data are expressed as the meansϮSE of triplicate independent determinations for each experiment except the cytokine array. Statistical significance was analyzed by Student's t-test, or one-or two-way analyses of variance with Turkey's post hoc testing. Statistical analysis was performed with JMP statistical software version 11.2.0 (SAS Institute, Cary, NC), and statistically significant differences were set at pϽ0.05.
RESULTS
We examined the effect of intestinal epithelial cells stimulated by caffeine (10 mmol/L) on lipid accumulation in 3T3-L1 adipocytes. Treatment with CCM miniaturized lipid droplets ( Fig. 2A) and significantly decreased lipid accumulation in 3T3-L1 cells (Fig. 2B) . Ingested caffeine was metabolized by cytochrome P450 (21) . We hypothesized that caffeine metabolites miniaturized lipid droplets. We determined the concentration of caffeine and its metabolites in CCM by HPLC analysis. The peaks of caffeine and its metabolites (theobromine, theophylline, 1-methylxanthine and 1,7-dimethyl uric acid) were well resolved (Fig. 2C, top panel) . CCM included the caffeine (28 mol/L) (Fig. 2C, middle  panel) , whereas caffeine was not detected in nontreated medium (Fig. 2C, bottom panel) . On the other hand, no caffeine metabolites were detected (data not shown). We also examined the effect of caffeine on lipid accumulation after direct application to adipocytes. As shown in Fig. 2D , caffeine itself did not affect lipid accmulation by 50 mol/L in 3T3-L1 cells. These results indicate that caffeine decreases lipid accumulation in 3T3-L1 cells indirectly through the stimulation of Caco-2 cells. We next investigated the changes in the expression levels of adipocyte-specific differentiation markers in 3T3-L1 cells after treatment with CCM. CCM significantly decreased the mRNA levels of PPAR␥ and C/EBP␣ (Fig. 3A) . In addition, CCM also decreased the gene expression of adiponectin (Fig. 3A) . As an expression of adipocyte differentiation during the early stages, CCM decreased the protein levels of C/EBP␤ and C/EBP␦ (Fig.  3B) , whereas it did not affect their mRNA levels (Fig.  3C) .
To determine whether CCM promotes degradation of C/EBP␤ and C/EBP␦ proteins, 3T3-L1 cells were co-incubated with CCM and the proteasome inhibitor MG132. As shown in Fig. 4A , MG132 increased their protein levels and canceled the CCM-induced decrease of C/EBP␤ and C/EBP␦ proteins. Furthermore, result from the immunoprecipitation assay showed that the CCM increases complex formation between ubiquitin and C/ EBP␤, and C/EBP␦ (Fig. 4B) . These results indicate that CCM induces degradation of C/EBP␤ and C/EBP␦ protein through the ubiquitin-proteasome pathway.
To investigate the effect of caffeine treatment on cytokine secretion from Caco-2 cells, we analyzed cytokine levels in CCM using protein array. Caco-2 cells secreted some cytokines, and the secretion level of interleukin-8 and plasminogen activator inhibitor (PAI)-1 was increased more by 24 h-incubation than that by 2 h-incubation (Fig. 5A) . Caffeine treatment increases secretion levels of G-CSF (1.55-fold) from Caco-2 cells (Fig. 5B) . In contrast, caffeine decreased secretion of some cytokines from Caco-2. In particular, caffeine downregulated secretion of PAI-1 (0.79-fold) and IL-8 (0.57-fold) levels from Caco-2 cells. Furthermore, we determined whether caffeine regulates the mRNA expression levels of PAI-1 and IL-8 in Caco-2 cells. Caffeine suppressed the gene expression of SERPINE1, encoding PAI-1 (Fig. 6) . These results indicate that caffeine increases secretion of anti-inflammatory cytokine G-CSF and decreases secretion of pro-inflammatory cytokines PAI-1 and IL-8.
DISCUSSION
Obesity is the main cause of metabolic syndrome. Many studies have documented that adipocyte differentiation and lipid accumulation are associated with the development of obesity. Certain dietary compounds derived from plants are considered to be a prescription for anti-obesity by suppression of adipocyte differentiation and regulation of lipid metabolism in culture cells and animal experiments (22) (23) (24) . However, there is little research that shows the effect of dietary compounds on adipogenesis through stimulation of intestinal epithelial cells. This study reports that caffeine-stimulated medium from Caco-2 cells suppresses adipogenesis in 3T3-L1 cells.
Our results show the indirect effect of caffeine against anti-lipid accumulation through intestinal epithelial cells (Fig. 2) . Some studies have reported the effect of caffeine against anti-lipid accumulation in vitro and in vivo. Caffeine decreases lipid accumulation by suppression of insulin-stimulated glucose uptake in 3T3-L1 adipocytes (15) . Furthermore, a high concentration of caffeine suppresses the protein expression of C/EBP␤ through regulating mitotic clonal expansion in 3T3-L1 adipocytes. On the other hand, a combination of caffeine and other food components exhibits anti-obesity effects in vitro and in vivo (25, 26) , indicating that caffeine supports the anti-obesity effect of other food components. Taken together, these results demonstrate that caffeine has direct and indirect effects against lipid accumulation.
Caffeine decreased the expression of pro-inflammatory cytokines IL-8 and PAI-1 in Caco-2 cells (Fig. 4B) . Pro-inflammatory cytokines from other tissues promote lipid accumulation in adipocytes. PAI-1 belongs to a family of serine protease inhibitors, and an increased plasma PAI-1 level has been associated with insulin resistance (27) . Knockout of PAI-1 suppresses weight gain in mice (28) , and some pharmacological inhibitors of PAI-1 improve high fat diet-induced obesity in mice (29, 30) , indicating that inhibition of PAI-1 reduces adipogenesis. Although IL-8 increases the leptin secretion in human adipocytes (31) , the effect of IL-8 derived from Caco-2 on fat accumulation in adipocytes is unclear.
Further studies are needed to analyze the effect of Caco-2-derived IL-8 on adipogenesis. On the other hand, our results also showed caffeine increased the secretion level of anti-inflammatory cytokine G-CSF (Fig. 4B) . G-CSF belongs to the class-1 cytokine superfamily, and the cytokines in this superfamily play an important role in energy homeostasis and exert anti-obesity effects (32, 33) . Intraperitoneal administration of G-CSF decreased body weight and increased energy expenditure in diabetic model rats (12) . These results indicate that caffeine-stimulated medium suppresses lipid accumulation through decreased secretion levels of PAI-1 and IL-8 from Caco-2 cells.
The secretion of IL-8 and PAI-1 is induced by inflammatory cytokines, oxidative stress and heavy metals.
Some studies have reported that food factors suppress inflammation and reduce the secretion of pro-inflammatory cytokines in intestinal epithelial cells. Soy isoflavone reduces the secretion of TNF-␣-induced IL-8, but not of hydrogen peroxide-induced IL-8 (34) . Histamine inhibits TNF-␣-and oxidative stress-induced IL-8 secretion in Caco-2 cells (35) . Orally administered caffeine decreases pro-inflammatory cytokines (TNF-␣ and IL-17F) and increases anti-inflammatory cytokines IL-10 in mouse colons (36) . Furthermore, caffeine attenuates acute colitis in a dextran sodium sulfate-induced model of accumulated oxidative stress (36) . These results suggest that caffeine decreases gene expression of PAI-1 and IL-8 through suppression of inflammation or oxidative stress in Caco-2 cells.
CCM induced degradation of C/EBP␤ and C/EBP␦ protein (Fig. 3) . Knockout of C/EBP␤ suppresses fat accumulation in mice fed a high-fat diet (37) . Thus, suppression of C/EBP␤ expression is an attractive target for diet-induced obesity. Food factors suppress the gene expression of C/EBP␤ through regulation of mitotic clonal expansion in 3T3-L1 adipocytes and zebrafish (38, 39) . In addition, direct treatment with caffeine also suppresses mitotic clonal expansion in 3T3-L1 adipocytes (40) . However, little is known about food factors which promote the degradation of C/EBP␤ protein. C/ EBP␤ protein is degraded by the proteasome pathway through increasing its ubiquitination (41) . Our results showed that CCM promoted ubiquitination of C/EBP␤ (Fig. 3B) . Thus, CCM might induce the expression of ubiquitin ligase, but not regulate mitotic clonal expansion in 3T3-L1 adipocytes.
In this study, Caco-2 cells were treated with caffeine at 10 mmol/L. Caffeine is included in various kinds of food and drink, such as coffee and green tea. The concentrations of caffeine contained in coffee are highly variable and are influenced by the extraction method. In the case of espresso, the caffeine content (25 mL) ranged from 111.21 to 257.57 mg (ϭfrom 11.5 to 26.5 mmol/L) (42) . Moreover, Crozier et al. report that the median value of caffeine content among 20 commercial espresso coffees is 140 mg/43 mL (ϭ17.1 mmol/mL) (43) . Taken together, we consider that when people drank a cup of espresso, epithelial cells in the gastrointestinal tract are exposed to caffeine at about 10 mmol/L and suggest that caffeine at 10 mmol/L is a physiological concentration for Caco-2 cells.
In conclusion, this study shows that caffeine decreases lipid accumulation through regulation of cytokine secretion from intestinal epithelial cells. It is important to understand the regulation of crosstalk between the intestinal cells and other cells by dietary components, in addition to regulation of their absorption in intestinal cells.
